Sonnet BioTherapeutics Holdings Inc
NASDAQ:SONN 4:00:00 PM EDT
Sonnet BioTherapeutics Holdings Inc Stock, NASDAQ:SONN
100 Overlook Center, Suite 102, Princeton, New Jersey 08540
United States of America
Phone: +1.609.375.2227
Number of Employees: 12
Description
Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its pipeline focuses on cytokines, a class of cell signaling peptides that, among other important functions, serve as potent immunomodulatory agents. The company was founded in 2011 and is headquartered in Princeton, NJ.